Prosecution Insights
Last updated: November 20, 2026

Carla J Myers, USPTO Patent Examiner

Listed by the USPTO as MYERS, CARLA J

Tech Center 1600 • Art Units: 1600 1613 1634 1671 1678 1682

This examiner grants 50% of resolved cases

Analysis

MYERS, CARLA J handles cases in tech center 1600 and art unit 1600. The profile covers 1043 resolved cases, with an allowance rate of 49.6%, an interview lift of 45.9%, and a median time to allowance of 1139 days.

The 49.6% allowance rate indicates a mixed outcome record, while the 45.9% interview lift is a strong separate signal for prosecution tactics. Interviews may merit deliberate use alongside focused claim amendments and arguments. The listed companies are Illumina Inc., The Children's Hospital of Philadelphia, and BIOASTER. The listed firms are HOWSON & HOWSON LLP, OLIFF PLC, and CHRISTENSEN O'CONNOR JOHNSON KINDNESS PLLC.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

49.6%
Allow Rate
-10.4% vs TC avg
1,093
Total Applications
+45.9%
Interview Lift
1139
Avg Prosecution Days
Based on 1043 resolved cases, 2023–2026

Rejection Statute Breakdown

22.5%
§101 Eligibility
15.2%
§102 Novelty
19.0%
§103 Obviousness
34.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18717006 SINGLE-CELL CULTURE AND SEQUENCING WITH LIPID-MODIFIED OLIGOS Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
18706182 IMMUNOTHERAPY TARGETING Non-Final OA The Regents of the University of California
18606690 METHODS, COMPOSITIONS, AND SYSTEMS FOR CAPTURING PROBES AND/OR BARCODES Non-Final OA 10x Genomics, Inc.
18023249 TARGET MEASUREMENT METHOD, TARGET MEASUREMENT DEVICE, TARGET MEASUREMENT APPARATUS, AND TARGET MEASUREMENT KIT Non-Final OA Yokogawa Electric Corporation
18540667 METHODS AND COMPUTER PRODUCTS FOR MEASURING THE AMOUNT OF CELLS OF A PARTICULAR CELL LINEAGE Non-Final OA The Chinese University of Hong Kong
18265029 A METHOD FOR CLASSIFYING THE GUT INFLAMMATION STATUS IN AVIAN SPECIES Final Rejection Evonik Operations GmbH
18044471 GENETIC ALTERATIONS ASSOCIATED WITH EOSINOPHILIC ESOPHAGITIS AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF DISEASE Non-Final OA THE CHILDREN'S HOSPITAL OF PHILADELPHIA
17641502 COMPOSITIONS COMPRISING RARE GENETIC SEQUENCE VARIANTS ASSOCIATED WITH PULMONARY FUNCTION AND METHODS OF USE THEREOF FOR DIAGNOSIS AND TREATMENT OF ASTHMA IN AFRICAN AMERICAN PATIENTS Non-Final OA THE CHILDREN'S HOSPITAL OF PHILADELPHIA
17429281 ISOLATION AND DETECTION OF EXOSOME-ASSOCIATED MICROBIOME FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES Non-Final OA Board of Regents, The University of Texas System
18290138 CD274 MUTATIONS FOR CANCER TREATMENT Non-Final OA Foundation Medicine, Inc.
18420482 INFERRING MICROORGANISM OF ORIGIN FOR ANTIMICROBIAL RESISTANCE MARKERS IN TARGETED METAGENOMICS Non-Final OA Illumina, Inc.
17026069 METHODS AND COMPOSITIONS FOR IDENTIFYING LIGANDS ON ARRAYS USING INDEXES AND BARCODES Non-Final OA ILLUMINA, INC.
17840801 METHOD OF DIAGNOSIS OF HEMOPHILIA Final Rejection Machaon Diagnostics, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Carla J Myers's allowance rate?

49.6% of resolved applications examined by Carla J Myers were allowed (1,043 resolved cases), compared with 36.5% across Art Unit 1600 over the last five years.

Does an interview help with examiner Carla J Myers?

This examiner's interview lift is +45.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Carla J Myers take to allow a patent?

Applications allowed by Carla J Myers took 1,139 days on average from filing to allowance.

Which art unit does examiner Carla J Myers work in?

Carla J Myers examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month